EXMceuticals Inc.
EXM.CN
Canadian Securities Exchange0.20
CAD
- -
- -
Return %
Stock
S&P500
1Y
- -
26.53
3Y
-50.00
76.60
5Y
48.15
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Julie Lemieux
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 421 7th Avenue SW Calgary AB Canada T2P 4K9
- IPO Date
- Sep 8, 2010
- Website
- exmceuticals.com
- Similar Companies
- Business
- EXMceuticals Inc. (CSE: EXM) is a bio-sciences company focused on the cultivation of cannabis and hemp and the production of high-grade cannabinoid formulations and ingredients for the pharmaceutical, nutraceutical, cosmeceutical, and medical cannabis industries; it offers refined cannabis extracts, distillates, isolates, active pharmaceutical ingredients, hemp oils, and infused products including capsules and oils for wholesale B2B distribution to international customers in healthcare and wellness sectors. The company, founded in 2017 and formerly headquartered in Vancouver, British Columbia, Canada, maintains production licenses in Africa, processing operations in Lisbon, Portugal through its former subsidiary EXMceuticals Portugal Lda—which specialized in phytochemical-based biopharmaceuticals and received EU and Portuguese government grants for COVID-19 biocides and cannabinoid cosmeceutical projects—and partnerships such as with NOVA University of Lisbon for research and development. Geographically, EXMceuticals operates across Europe, North America, and Africa, targeting medicinal cannabis wholesalers and serving global markets with GMP-compliant products. In recent developments, the company signed a definitive business combination agreement in May 2021 with Global Cannabinoids, a U.S.-based B2B distributor of hemp-derived cannabinoids, to create a combined entity focused on expanded hemp and CBD distribution, though the transaction was ultimately cancelled; it sold EXMceuticals Portugal Lda in April 2022 for €0.08 million; and its common shares were delisted from the Canadian Securities Exchange effective December 12, 2023.